The FDA extended Tivicay PD to newborns from birth weighing at least 2 kg, closing a long-standing gap in infant HIV treatment options.
Newborns with HIV Can Now Get a Second Generation Antiviral from Birth Under a Newly Expanded Federal Label
by | Aug 26, 2026 | Uncategorized | 0 comments

Recent Comments